NCT07328113Completed
Interleukin-6 and Thyroid Dysfunction in Hemodialysis Patients
Association Between Interleukin-6 and Thyroid Hormone Dysfunction in Patients With Chronic Kidney Disease Undergoing Hemodialysis
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
Chronic kidney disease (CKD) is often associated with multiorgan complications, including thyroid hormone dysfunction. Interleukin-6 (IL-6), a pro-inflammatory cytokine, has been proposed as a marker of inflammation that may contribute to these alterations. The main question it aims to answer is: Is there an association between interleukin-6 and thyroid hormone dysfunction in patients with chronic kidney disease (CKD) Blood samples will be collected and analyzed from 65 patients who have undergone hemodialysis for at least 3 months.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 65 (actual)
- First submitted
- 25 Nov 2025
- Start date
- Nov 2023
- Primary completion date
- Mar 2024
- Lead sponsor
- Dr. Soetomo General Hospital
- Diseases
- Chronic kidney disease
- NCT number
- NCT07328113
What you commit to
- Study type: Observational
- Participants enrolled: 65
- From Nov 2023 to the primary completion date, Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients taking medications that affect thyroid function or using antioxidant drugs.
Other illness
- ESRD patients undergoing hemodialysis who have been diagnosed with underlying thyroid disorders or thyroid malignancy.
- Patients with a history of thyroid surgery or any intervention involving the thyroid gland.
- Patients with a family history of thyroid disorders.
- Patients with infection or sepsis.
Who the study is looking for
- Age 21 Years Old and above
- Patients with ESRD who have undergone hemodialysis for ≥ 3 months and are in stable condition.
- Patients are able to communicate and respond to questions appropriately
- Patients are willing to participate in the study.
Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Airlangga University Hospital Coordinator of this site? Confirm its status | Surabaya | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.